One 2-hour zoom class may ease chronic migraine disability
NCT ID NCT05979337
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a brief behavioral class called Empowered Relief can reduce disability and symptoms in adults with chronic migraine. 300 participants will be randomly assigned to the class, a health education session, or usual care, all done remotely. The goal is to see if learning pain psychology and neuroscience in a single session can make a real difference in daily life.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Empowered Relief (a single-session behavioral class using pain psychology and education)
- What this could lead to
- If it works, this could offer a simple, accessible way to reduce migraine-related disability and improve daily life without medication.
- What could go wrong
- This is a behavioral intervention, not a cure. Results may be modest, and benefits might not last long-term. The study is not blinded, so expectations could influence outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a No-Fridge migraine shot replace botox?
- Could a common cholesterol drug stop chronic migraine?
- Migraine relief may sharpen the mind: study investigates cognitive benefits of preventive therapies
- New combo therapy for chronic migraine: atogepant plus botox under study
- Thousands to test new migraine meds in largest Real-Life study
- New migraine drug shows promise in Real-World study